Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 16, 2011
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe
, , Fumiyo Nakagawa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 11, 2020
Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting
Lauren Greenberg, Lene Ryom, Gilles Wandeler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 12, 2018
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
Luuk Gras, Margaret May, Lars Peter Ryder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study
Hortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
Plos One
|
December 31, 2020
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium
Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 23, 2020
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus
Lauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
The Lancet. HIV
|
September 23, 2021
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium
Loveleen Bansi-Matharu, Andrew Phillips, Cristiana Oprea, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 25, 2014
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery
Frederik N Engsig, Robert Zangerle, Olga Katsarou, et al.
Emerging Infectious Diseases
|
February 21, 2018
New Lineage of Lassa Virus, Togo, 2016
Shannon L M Whitmer, Thomas Strecker, Daniel Cadar, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 16, 2011
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe
, , Fumiyo Nakagawa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 11, 2020
Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting
Lauren Greenberg, Lene Ryom, Gilles Wandeler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 12, 2018
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
Luuk Gras, Margaret May, Lars Peter Ryder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study
Hortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
Plos One
|
December 31, 2020
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium
Bastian Neesgaard, Amanda Mocroft, Robert Zangerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 23, 2020
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus
Lauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
The Lancet. HIV
|
September 23, 2021
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium
Loveleen Bansi-Matharu, Andrew Phillips, Cristiana Oprea, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 25, 2014
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery
Frederik N Engsig, Robert Zangerle, Olga Katsarou, et al.
Emerging Infectious Diseases
|
February 21, 2018
New Lineage of Lassa Virus, Togo, 2016
Shannon L M Whitmer, Thomas Strecker, Daniel Cadar, et al.
Page
of 15